Cargando…

Gene expression patterns associated with p53 status in breast cancer

BACKGROUND: Breast cancer subtypes identified in genomic studies have different underlying genetic defects. Mutations in the tumor suppressor p53 occur more frequently in estrogen receptor (ER) negative, basal-like and HER2-amplified tumors than in luminal, ER positive tumors. Thus, because p53 muta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Troester, Melissa A, Herschkowitz, Jason I, Oh, Daniel S, He, Xiaping, Hoadley, Katherine A, Barbier, Claire S, Perou, Charles M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1764759/ https://www.ncbi.nlm.nih.gov/pubmed/17150101 http://dx.doi.org/10.1186/1471-2407-6-276

Ejemplares similares

The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas
por: Herschkowitz, Jason I, et al.
Publicado: (2008)

Prediction of Toxicant-Specific Gene Expression Signatures after Chemotherapeutic Treatment of Breast Cell Lines
por: Troester, Melissa A., et al.
Publicado: (2004)

TP53 Pathway Function, Estrogen Receptor Status, and Breast Cancer Risk Factors in the Carolina Breast Cancer Study
por: Hurson, Amber N., et al.
Publicado: (2022)

EGFR associated expression profiles vary with breast tumor subtype
por: Hoadley, Katherine A, et al.
Publicado: (2007)

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
por: Prat, Aleix, et al.
Publicado: (2010)

Prognostic significance of RNA-based TP53 pathway function among estrogen receptor positive and negative breast cancer cases
por: Hurson, Amber N., et al.
Publicado: (2022)

TP53 protein levels, RNA-based pathway assessment, and race among invasive breast cancer cases
por: Williams, Lindsay A., et al.
Publicado: (2018)

Impact of stromal microenvironment on metabolic phenotypes in breast cancer: evidence for stroma-influenced Warburg effect
por: Brauer, Heather Ann, et al.
Publicado: (2012)

Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling
por: Zhao, Wei, et al.
Publicado: (2014)

Molecular features of the basal-like breast cancer subtype based on BRCA1 mutation status
por: Prat, Aleix, et al.
Publicado: (2014)

Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes
por: Prat, Aleix, et al.
Publicado: (2013)

Identification of mRNA isoform switching in breast cancer
por: Zhao, Wei, et al.
Publicado: (2016)

Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancers
por: Pfefferle, Adam D., et al.
Publicado: (2016)

Potential Tumor Suppressor Role for the c-Myb Oncogene in Luminal Breast Cancer
por: Thorner, Aaron R., et al.
Publicado: (2010)

Inherited predisposition to breast cancer in the Carolina Breast Cancer Study
por: Walsh, Tom, et al.
Publicado: (2021)

Predicting early breast cancer recurrence from histopathological images in the Carolina Breast Cancer Study
por: Shi, Yifeng, et al.
Publicado: (2023)

Micro-Scale Genomic DNA Copy Number Aberrations as Another Means of Mutagenesis in Breast Cancer
por: Chao, Hann-Hsiang, et al.
Publicado: (2012)

Image analysis with deep learning to predict breast cancer grade, ER status, histologic subtype, and intrinsic subtype
por: Couture, Heather D., et al.
Publicado: (2018)

Molecular signatures of in situ to invasive progression for basal-like breast cancers: An integrated mouse model and human DCIS study
por: Thennavan, Aatish, et al.
Publicado: (2022)

RNA-Based Classification of Homologous Recombination Deficiency in Racially Diverse Patients with Breast Cancer
por: Walens, Andrea, et al.
Publicado: (2022)

Integrated RNA and DNA sequencing improves mutation detection in low purity tumors
por: Wilkerson, Matthew D., et al.
Publicado: (2014)

Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures
por: Fan, Cheng, et al.
Publicado: (2011)

The molecular diversity of Luminal A breast tumors
por: Ciriello, Giovanni, et al.
Publicado: (2013)

A framework for transcriptome-wide association studies in breast cancer in diverse study populations
por: Bhattacharya, Arjun, et al.
Publicado: (2020)

Patterns of cell cycle checkpoint deregulation associated with intrinsic molecular subtypes of human breast cancer cells
por: Bower, Jacquelyn J., et al.
Publicado: (2017)

Outcomes of Hormone-Receptor Positive, HER2-Negative Breast Cancers by Race and Tumor Biological Features
por: Benefield, Halei C, et al.
Publicado: (2020)

Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple Metastases
por: Hoadley, Katherine A., et al.
Publicado: (2016)

Correction: Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple Metastases
por: Hoadley, Katherine A., et al.
Publicado: (2017)

Genetic determinants of the molecular portraits of epithelial cancers
por: Xia, Youli, et al.
Publicado: (2019)

Gene-Level Germline Contributions to Clinical Risk of Recurrence Scores in Black and White Patients with Breast Cancer
por: Patel, Achal, et al.
Publicado: (2022)

Identification of drug targets for the treatment of Basal-like tumors
por: Hoadley, KA, et al.
Publicado: (2005)

In Vitro and In Vivo Analysis of B-Myb in Basal-Like Breast Cancer
por: Thorner, AR, et al.
Publicado: (2008)

Incorporating RNA-based Risk Scores for Genomic Instability to Predict Breast Cancer Recurrence and Immunogenicity in a Diverse Population
por: Hamilton, Alina M., et al.
Publicado: (2023)

Beyond DNA: the Role of Epigenetics in the Premalignant Progression of Breast Cancer
por: DeVaux, Rebecca S., et al.
Publicado: (2018)

Race-associated biological differences among luminal A and basal-like breast cancers in the Carolina Breast Cancer Study
por: Parada, Humberto, et al.
Publicado: (2017)

Landscape of Genetic Alterations Underlying Hallmark Signature Changes in Cancer Reveals TP53 Aneuploidy–driven Metabolic Reprogramming
por: McClure, Marni B., et al.
Publicado: (2023)

Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1
por: Wright, Mollie H, et al.
Publicado: (2008)

Endothelial-like properties of claudin-low breast cancer cells promote tumor vascular permeability and metastasis
por: Harrell, J. Chuck, et al.
Publicado: (2013)

Spatial Characterization of Tumor-Infiltrating Lymphocytes and Breast Cancer Progression
por: Fassler, Danielle J., et al.
Publicado: (2022)

Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control study
por: Chollet-Hinton, Lynn, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_81e0vk8n17kij3godnbbde6106